PlasmaTech Biopharmaceuticals closes underwritten public offering of common …
News-Medical.net PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: PTBI, PTBIW), a biopharmaceutical company advancing patient care in critical areas, announced the closing of an underwritten public offering of 3,500,000 shares of common stock, and warrants to purchase … PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingCNNMoney |